Indirubin Derivative 7-Bromoindirubin-3-oxime (7bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice.
Liping Chen,Chunhui Huang,Jieyi Shentu,Minjun Wang,Sicheng Yan,Fei Zhou,Zaijun Zhang,Chuang Wang,Yifan Han,Qinwen Wang,Wei Cui
DOI: https://doi.org/10.3389/fnmol.2017.00393
2017-01-01
Frontiers in Molecular Neuroscience
Abstract:Indirubins are natural occurring alkaloids extracted from indigo dye-containing plants. Indirubins could inhibit various kinases, and might be used to treat chronic myelocytic leukemia, cancer and neurodegenerative disorders, 7-bromoindirubin-3-oxime (7Bio), an indirubin derivative derived from indirubin-3-oxime, possesses inhibitory effects against cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3 beta (GSK3 beta), two pharmacological targets of Alzheimer's disease (AD). In this study, we have discovered that 2.3-23.3 (mu g/kg 7Bio effectively prevented beta-amyloid (A beta) oligomer-induced impairments of spatial cognition and recognition without affecting bodyweight and motor functions in mice. Moreover, 7Bio potently inhibited A beta oligomer-induced expression of interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-alpha). Furthermore, 7Bio significantly prevented the decreased expression of synapsin-1 and PSD-95, biomarkers of pre-synaptic and post-synaptic proteins in A beta oligomer-treated mice. The mean optical density (OD) with hyper-phosphorylated tau (pTau), glial fibrillary acidic protein (GFAP) and CD45 positive staining in the hippocampus of 7Bio-treated mice were significantly decreased compared to those of A beta oligomer-treated mice. In addition, Western blotting analysis showed that 7Bio attenuated A beta oligomer-decreased expression of pSer9-GSK3 beta. Those results suggested that 7Bio could potently inhibit A beta oligomer-induced neuroinflammation, synaptic impairments, tau hyper-phosphorylation, and activation of astrocytes and microglia, which may contribute to the neuroprotective effects of 7Bio. Based on these findings, we expected that 7Bio might be developed as a novel anti-AD lead compound.